These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16638566)

  • 81. Programmed ribosomal frameshifting in HIV-1 and the SARS-CoV.
    Brierley I; Dos Ramos FJ
    Virus Res; 2006 Jul; 119(1):29-42. PubMed ID: 16310880
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease.
    Frieman M; Yount B; Agnihothram S; Page C; Donaldson E; Roberts A; Vogel L; Woodruff B; Scorpio D; Subbarao K; Baric RS
    J Virol; 2012 Jan; 86(2):884-97. PubMed ID: 22072787
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Real-time polymerase chain reaction for detecting SARS coronavirus, Beijing, 2003.
    Zhai J; Briese T; Dai E; Wang X; pang X; Du Z; Liu H; Wang J; Wang H; Guo Z; Chen Z; Jiang L; Zhou D; Han Y; Jabado O; Palacios G; Lipkin WI; Tang R
    Emerg Infect Dis; 2004 Feb; 10(2):300-3. PubMed ID: 15030701
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Cloning, expression and purification of SARS coronavirus PUMC2 strain nucleocapsid protein].
    Tan XY; Fan Z; Wang HJ; Shi L; Yin B; Ni AP; Qin C; Zou K; Shen Y; Yuan JG; Qiang BQ; Peng XZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):504-7. PubMed ID: 14650145
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China.
    Guan Y; Zheng BJ; He YQ; Liu XL; Zhuang ZX; Cheung CL; Luo SW; Li PH; Zhang LJ; Guan YJ; Butt KM; Wong KL; Chan KW; Lim W; Shortridge KF; Yuen KY; Peiris JS; Poon LL
    Science; 2003 Oct; 302(5643):276-8. PubMed ID: 12958366
    [TBL] [Abstract][Full Text] [Related]  

  • 86. siRNA-Mediated Simultaneous Regulation of the Cellular Innate Immune Response and Human Respiratory Syncytial Virus Replication.
    Martín-Vicente M; Resino S; Martínez I
    Biomolecules; 2019 Apr; 9(5):. PubMed ID: 31035368
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The 7a accessory protein of severe acute respiratory syndrome coronavirus acts as an RNA silencing suppressor.
    Karjee S; Minhas A; Sood V; Ponia SS; Banerjea AC; Chow VT; Mukherjee SK; Lal SK
    J Virol; 2010 Oct; 84(19):10395-401. PubMed ID: 20631126
    [TBL] [Abstract][Full Text] [Related]  

  • 88. VIRsiRNApred: a web server for predicting inhibition efficacy of siRNAs targeting human viruses.
    Qureshi A; Thakur N; Kumar M
    J Transl Med; 2013 Dec; 11():305. PubMed ID: 24330765
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque.
    Li BJ; Tang Q; Cheng D; Qin C; Xie FY; Wei Q; Xu J; Liu Y; Zheng BJ; Woodle MC; Zhong N; Lu PY
    Nat Med; 2005 Sep; 11(9):944-51. PubMed ID: 16116432
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Application of siRNA against SARS in the rhesus macaque model.
    Tang Q; Li B; Woodle M; Lu PY
    Methods Mol Biol; 2008; 442():139-58. PubMed ID: 18369784
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Structural considerations in the fitness landscape of a virus.
    Watabe T; Kishino H
    Mol Biol Evol; 2010 Aug; 27(8):1782-91. PubMed ID: 20194425
    [TBL] [Abstract][Full Text] [Related]  

  • 92. More mysteries of HIV and SARS are revealed.
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):353-4. PubMed ID: 16771611
    [No Abstract]   [Full Text] [Related]  

  • 93. The coronavirus replicase: insights into a sophisticated enzyme machinery.
    Ziebuhr J
    Adv Exp Med Biol; 2006; 581():3-11. PubMed ID: 17037497
    [No Abstract]   [Full Text] [Related]  

  • 94. RNAi suppressor: The hidden weapon of SARS-CoV.
    Karjee S; Mukherjee SK
    J Biosci; 2020; 45(1):. PubMed ID: 32713862
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A new coronavirus associated with human respiratory disease in China.
    Wu F; Zhao S; Yu B; Chen YM; Wang W; Song ZG; Hu Y; Tao ZW; Tian JH; Pei YY; Yuan ML; Zhang YL; Dai FH; Liu Y; Wang QM; Zheng JJ; Xu L; Holmes EC; Zhang YZ
    Nature; 2020 Mar; 579(7798):265-269. PubMed ID: 32015508
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
    Lu R; Zhao X; Li J; Niu P; Yang B; Wu H; Wang W; Song H; Huang B; Zhu N; Bi Y; Ma X; Zhan F; Wang L; Hu T; Zhou H; Hu Z; Zhou W; Zhao L; Chen J; Meng Y; Wang J; Lin Y; Yuan J; Xie Z; Ma J; Liu WJ; Wang D; Xu W; Holmes EC; Gao GF; Wu G; Chen W; Shi W; Tan W
    Lancet; 2020 Feb; 395(10224):565-574. PubMed ID: 32007145
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection.
    Chen P; Wu M; He Y; Jiang B; He ML
    Signal Transduct Target Ther; 2023 Jun; 8(1):237. PubMed ID: 37286535
    [TBL] [Abstract][Full Text] [Related]  

  • 98. From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis.
    Yogev O; Weissbrod O; Battistoni G; Bressan D; Naamati A; Falciatori I; Berkyurek AC; Rasnic R; Izuagbe R; Hosmillo M; Ilan S; Grossman I; McCormick L; Honeycutt CC; Johnston T; Gagne M; Douek DC; Goodfellow I; Hannon GJ; Erlich Y
    Commun Biol; 2023 Mar; 6(1):277. PubMed ID: 36928598
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Genome wide screen of RNAi molecules against SARS-CoV-2 creates a broadly potent prophylaxis.
    Yogev O; Weissbrod O; Battistoni G; Bressan D; Naamti A; Falciatori I; Berkyurek AC; Rasnic R; Hosmillo M; Ilan S; Grossman I; McCormick L; Honeycutt CC; Johnston T; Gagne M; Douek DC; Goodfellow I; Hannon GJ; Erlich Y
    bioRxiv; 2022 Apr; ():. PubMed ID: 35441162
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Antisense technology as a potential strategy for the treatment of coronaviruses infection: With focus on COVID-19.
    Alavizadeh SH; Doagooyan M; Zahedipour F; Torghabe SY; Baharieh B; Soleymani F; Gheybi F
    IET Nanobiotechnol; 2022 May; 16(3):67-77. PubMed ID: 35274474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.